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4Abstract 
Background:  Following passage of the Affordable Care Act in 2010, 30-day 
hospital readmissions have come under greater scrutiny.  Excess readmissions 
for certain medical conditions and procedures now result in penalizations on all 
Medicare reimbursements.  We examined the risk factors, outcomes, and costs 
of 30-day readmissions after colorectal surgery (CRS). 
Methods:   The University HealthSystem Consortium database was queried for 
adults (≥ 18 years) who underwent colorectal resection for cancer, diverticular 
disease, inflammatory bowel disease, or benign tumors between January 2008 
and December 2011.  Our outcomes of interest were readmission within 30-days 
of the patient’s index discharge, hospital readmission outcomes, and total direct 
hospital costs. 
Results:  A total of 70,484 patients survived the index hospitalization after CRS 
during the years under study, 13.7% (9,632) of which were readmitted within 30 
days of discharge.  The strongest independent predictors of readmission were: 
LOS ≥4 days (OR 1.44; 95% CI 1.32-1.57), stoma (OR 1.53; 95% CI 1.45-1.61), 
and discharge to skilled nursing (OR 1.63; 95% CI 1.49-1.76) or rehabilitation 
facility (OR 2.93; 95% CI 2.54-3.40).   Of those readmitted, half occurred within 7 
days of the index admission, 13% required ICU care, 6% had a reoperation, and 
2% died during the readmission stay.  The median combined total direct hospital 
cost was over twice as high ($26,917 v. $13,817) for readmitted than for non-
readmitted patients.  
5Conclusions:  Readmissions following colorectal resection occur frequently and 
incur a significant financial burden on the healthcare system.  Future studies 
aimed at targeted interventions for high-risk patients may reduce readmissions 
and curb escalating healthcare costs. 
 
Categorization: Outcomes research; Cost analysis; Colon and Rectal Surgery 
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Chapter I: Introduction 
 
Scrutiny of 30-day Readmissions 
In 2007, the Medicare Payment Advisory Commission made a report to 
Congress that outlined a total reimbursement for hospital readmissions of $15 
billion for the year 2005. [1]  Upon further analysis of the Medicare 
hospitalizations that year, it was noted that 18% were readmissions that 
occurred within the first 30 days of the patient’s index discharge, resulting in this 
staggering cost.  Additionally,, only half of the readmitted patients were seen by 
a provider between the time of discharge and readmission.  The most common 
conditions associated with hospital readmissions were myocardial infarction, 
chronic obstructive pulmonary disease, and pneumonia.  Based on these 
findings, the commission deemed 80% of these readmission hospitalizations to 
be “potentially avoidable.”   
In response to this, as a part of the Patient Protection and Affordable 
Care Act, the Hospital Readmissions Reduction Program (HRRP) was formed 
[2].  In an effort to reduce potentially avoidable readmissions, the HRRP 
penalizes hospitals for readmissions for certain conditions, in excess of their 
risk-adjusted expected rates.  This puts the burden of reducing readmissions on 
the hospital [3].  Beginning in 2012, the Centers for Medicare and Medicaid 
Services began penalizing hospitals for patients with a diagnosis of myocardial 
infarction, chronic obstructive pulmonary disease, and pneumonia.  These 
penalties are levied on all Medicare reimbursements for the hospital, regardless 
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of the condition or procedure, making the disincentive quite large.  The 
maximum penalty began at 1% of all Medicare reimbursements for the hospital 
but has increased to 3%, and may continue to rise in future.  This list of covered 
conditions in the HRRP expanded to total knee and hip arthroplasty in October 
2013, and is expected to expand further to include cardiovascular procedures in 
2014.[4]  The HRRP allows for expansion to additional conditions and surgical 
procedures at anytime.  
Colorectal Surgery Readmissions 
Of the 600,000 patients who annually undergo colorectal surgery (CRS), 
up to 1 in every 4 will be readmitted within the first 30 days of initial discharge.[5]  
This represents a significant burden on the healthcare system, with 
readmissions following colon cancer operations accounting for $300 million 
annually.[6]  With the current healthcare climate of increasing costs and the 
scrutiny of readmissions by the HRRP, CRS may provide an ideal target for 
future penalties, prompting clinicians to examine readmissions and reduce their 
occurrence. 
Readmissions following CRS has been extensively studied in the 
literature.[6-22]  However, objective evidence of the most important risk factors 
for hospital readmission does not exist as the studies that have been performed 
to date have yielded conflicting results.  Furthermore, only a minority of studies 
have assessed readmission risk with multivariable regression models.[6-22]  
Many of these studies have been limited by being single institution chart reviews 
with relatively small study size[7, 11, 13, 15, 19, 22], data from national cancer 
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registries from countries with national healthcare systems[8], or Medicare data 
specific to cancer diagnoses[10, 12], [20]. To date, factors found to be 
independently associated with readmission risk vary from sociodemographic to 
psychosocial, clinical, and perioperative.[7-18]  In addition to the limitations of 
prior studies in this area, their focus has been on the risk factors for 
readmission.  The outcomes and costs of readmission hospitalizations among 
CRS patients have been infrequently examined.{Greenblatt et al., 2010, #69810}
{Collins et al., 1999, #27898}   
 
 
National Surgical Quality Improvement Project 
A more promising database for addressing the problem of hospital 
readmissions among surgical patients is the National Surgical Quality 
Improvement Project (NSQIP). [23]  Each hospital has dedicated abstractors that 
collect data on patients undergoing specific surgical procedures every 1 in 8 
days, representing a sample of surgical patients from each hospital.  The data 
collected are rich in clinical information, from preoperative vital signs and lab 
values, to intraoperative blood loss, transfusion requirements, and to post-
operative complications and discharge information.  This database provides 
distinct advantages over many of the other large scale, multicenter databases 
available for analysis such as the Nationwide Inpatient Sample and Medicare.  
NSQIP also collects information on readmissions within 30 days of the index 
discharge and the reason(s) for readmission.   
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A recent report on readmissions after colorectal procedures using data 
from NSQIP found the strongest risk factor for readmission was post-operative 
complications. [24]  However, this study only represents a sample of the total 
patients undergoing colorectal surgery procedures.  Additionally, Wick et al, 
examined readmissions in a single institution study, comparing the readmissions 
captured for CRS patients in NSQIP, the University HealthSystem Consortium 
(UHC) Clinical Database, and by physician medical record review.  The authors 
found NSQIP to be less comprehensive, missing readmissions that were 
captured by UHC or physician review.[11]  Therefore, NSQIP, at this time, does 
not provide the best data with which to analyze hospital readmissions. 
 
University HealthSystem Consortium Clinical Database 
The UHC Clinical Database collects inpatient data from 120 participating 
academic medical centers and 300 of their affiliates, comprising nearly 95% of 
U.S. non-profit medical centers.  Variables collected include International 
Classification of Diseases, 9th edition (ICD-9) codes for diagnoses and 
procedures, physician specialty, length of stay, risk-adjusted severity of illness 
scores, and hospital associated costs.  The UHC converts hospital charges into 
cost-estimates based on federal-wage data for each hospital location, allowing 
for meaningful cost comparisons between centers, regardless of hospital 
location.  They also capture both the occurrence of 30-day readmissions as well 
as the complete encounter information for the readmission hospitalization.  
Although patients admitted to non-UHC hospitals are not included in the 
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database, it does provide for a thorough examination of the reasons for 
readmission, outcomes from the readmission hospitalization, as well as the 
associated total direct hospital costs.[25] 
 
Specific Aims 
The primary aim of this study was to identify patient-related risk factors for 
30-day readmission among adult patients following colorectal surgery 
procedures.  Secondary study aims included a description of the 
rehospitalization outcomes among these patients and assessment of the total 
direct hospital costs associated with readmission.  To meet these aims, we 
utilized the University HealthSystem Consortium Clinical Database to examine 
these outcomes among adult patients (≥ 18 years) who underwent colorectal 
surgery for both benign and malignant conditions between 2008 and 2011.  
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Chapter II: Study Methodology 
 
Patient Selection 
 Following exemption status by the University of Massachusetts Medical 
Center Institutional Review Board, the UHC database was queried for adult 
patients, 18 years or older, with procedure codes for several colorectal resection 
ICD-9 codes (17.33-36, 17.39, 45.7, 45.73-76, 45.79, 45.8, 45.81-82, 48.42, 
48.51-52, 48.62-63) performed between 2008 and 2011.  The cohort was limited 
to those with either a primary or secondary ICD-9 diagnosis of malignancy 
(153.X, 154.0-3, 154.48), diverticular disease (562.10-11, 562.12-13), 
inflammatory bowel disease (555.0-2, 555.9, 556.X) or benign neoplasm (211.3-
4).  These years were studied since they allowed for analysis of surgeon-volume, 
as the unique surgeon identification numbers changed in 2012.  Patients that 
died during their index hospitalization were excluded from this study since our 
primary outcome, readmission, required survival beyond the index stay. 
Outcome Measures 
The primary outcome of interest was all-cause 30-day hospital 
readmissions, as classified in the UHC database.  Secondary endpoints were: 
readmission diagnosis (categorized by primary ICD-9 diagnosis at readmission), 
reoperation during readmission stay (exploratory surgery, stoma 
creation/revision, resection), intensive care unit (ICU) stay during the 
readmission, readmission length of stay (LOS), total direct hospital costs at 
readmission (as reported by UHC), and combined total direct hospital costs 
16
(index hospitalization direct costs + readmission total direct costs), death during 
readmission, and readmission discharge disposition (home vs. non-home). 
Factors Associated with 30-Day Hospital Readmission Rates  
The covariates examined in relation to our primary study endpoint 
included age, gender, race, insurance status, comorbid diagnoses (based on 
ICD-9 diagnosis codes), 3M © APR-DRG Admission Severity of Illness Score 
(3M Health Information Systems, Salt Lake City, UT) recoded into low (minor 
and moderate) and high (major and extreme) for ease of analysis, inpatient post-
operative complications (e.g., stroke, pneumonia, hemorrhage/hematoma, 
reopening of surgical wound, cellulitis, urinary tract infection, myocardial 
infarction, venous thromboembolism, sepsis), ICU admission rate after the initial 
procedure, index hospitalization LOS, index hospitalization discharge status 
(home vs. non-home), indication for procedure (diagnosis type), laparoscopy use 
(vs. open surgery) and ostomy creation. Surgeon and hospital volume was 
categorized based on quartiles of annual colorectal procedure volume. 
Data Analysis   
 Univariate analysis was used to assess the demographic, clinical, and 
perioperative risk factors for 30-day hospital readmissions.  Selected continuous 
variables were analyzed by student’s t-test, while differences in categorical 
variables were examined by use of the chi-square test.   Multivariable logistic 
regression was used to assess independent predictors of readmission.  
Variables included in the adjusted analysis included those deemed important 
based on a priori knowledge and those found to be significantly different 
17
between those who were readmitted vs. those who were not on univariate 
analysis. All analyses were conducted with the use of Stata© IC version 12.1. 
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Chapter III: Study Results 
 
 Over the study period, 71,279 patients underwent colorectal resection for 
malignancy (n = 34,383), diverticular disease (n = 17,845), inflammatory bowel 
disease (n = 11,048), or benign tumor (n = 7,208), 795 of whom died during the 
index hospitalization, leaving 70,484 persons at risk for 30-day hospital 
readmissions.  The mean age of the study population was 59 years, half were 
male, 76% were white, and nearly half (49%) were privately insured.  The all-
cause 30-day readmission rate was 13.7%.   
Characteristics of readmitted vs. non-readmitted pts 
In examining differences between those readmitted (RD) during the 30 
days following CRS with those who were not (NRD), RD patients were likely to 
be slightly younger, male, black, and have public insurance (Table 1).  Comorbid 
conditions were more prevalent in the readmitted group, and 13% of RD patients 
were of high severity of illness, compared to 8% of NRD pts  (p<0.001).   
Patients who were readmitted were more likely to have a rectal resection, and 
less likely to have the procedure performed laparoscopically, than patients who 
were NRD (Table 2).  NRD patients were more likely to be operated on by very-
high volumes surgeons at very-high volume hospitals, though the absolute 
between group differences were  quite small. 
Outcomes of index hospitalization 
During the index hospitalization, patients who were readmitted had higher 
rates of post-operative complications, ICU admission, and non-home 
discharges, and longer LOS(Table 3).  Reoperation or percutaneous drain 
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placement occurred in 4% of the RD group, and only 2% of the NRD group.  
Median total direct costs for the index hospitalization were significantly higher in 
the RD group ($13,175 vs. $10,507,(p<0.001, data not shown).  The factors with 
the highest odds of readmission were non-home discharge (skilled nursing 
facility OR 1.63; 95% CI 1.49-1.76; rehabilitation facility OR 2.93; 95% CI 2.54-
3.40), stoma (OR 1.53; 95% CI 1.45-1.61), and LOS 4 days or longer (OR 1.44; 
95% CI 1.32-1.57) (Table 4). 
Outcomes of readmission hospitalization 
Evaluation of primary readmission diagnoses revealed gastrointestinal 
disorders (29%) and surgical site infections (28%) as the most common reasons 
for readmission (Table 5).  When the reasons for readmission were assessed in 
pts with the strongest risk factors identified (stoma creation, LOS ≥ 4 days, and 
non-home discharge), the readmission diagnoses were similar, although stoma 
patients had higher rates of readmission for fluid & electrolyte imbalance/failure 
to thrive, and organ space infection (Table 5). 
 The median time to readmission was 7 days (Figure 1).  Patients 
readmitted within 7 days of discharge (early readmissions [ER]) compared with 
those readmitted 8-30 days after discharge (late readmissions [LR]) were more 
likely to undergo reoperation (Table 6).  Intensive care unit rates and 
readmission LOS were higher among ER patients. The readmission mortality 
rate of 2% was no different between ER and LR patients. Median readmission 
total direct costs were slightly higher for ER patients compared with LR patients 
($4,489 vs. $4,396, p<0.001).  These readmission costs resulted in a combined 
20
cost of $9,148 higher for RD than NRD patients (median costs $19,655 vs. 
$10,507, p<0.001). 
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Chapter IV: Discussion 
 
In this large observational cohort study of adult men and women who 
underwent colorectal surgery for benign and malignant conditions over the 
period from January 2008 to December 201, we found a readmission rate of 
13.7%.  Several risk factors for 30-day readmission were identified including: 
index LOS 4 days or longer, stoma, and non-home discharge. The majority of 
30-day readmissions occurred within one week of index admission; the most 
common reasons were gastrointestinal and surgical site infection related.  
Outcomes from the readmission hospitalization were poor, with one in five 
patients requiring reoperation or percutaneous drain placement, 13% requiring 
ICU admission, a median LOS of 4 days, and a 2% mortality rate.    
Length of hospital stay  
 The relationship between shorter length of stay and increased 
readmission rates has been a debated topic in colorectal surgery, which was 
prompted by the introduction of enhanced recovery pathways (ERAS).  The 
concept of ERAS, was first introduced for CRS in 1995.[26]  Since then, 
numerous randomized controlled trials have indicated the safety and feasibility 
of shorter length of stay for CRS patients with no significant differences in 
readmission rates.[27]  We found that LOS was higher, on average,  for patients 
readmitted after surviving the hospital stay than those who were not readmitted.  
Length of stay 4 days or longer translated into a 40% higher readmission risk, 
after adjusting for relevant confounders.   The contribution by ERAS or other 
process/patient specific factors to shorter hospital stays and lower readmission 
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rates is unclear given the lack of granularity in the UHC database.    What is 
evident, based on our findings as well as that of previous studies, is the safety of 
early discharge of patients who meet pre-determined clinical criteria.    
Stoma 
In the present study, approximately 40% of readmitted patients had a 
stoma creation during the index hospitalization which was identified as a 
significant independent risk factor for readmission.  While clearly indicated in 
certain clinical scenarios,[7, 28] the impact of stomas on quality of life and on the 
health care system is unquestioned.[29]  
Well known to clinicians, a frequently encountered complication of stomas 
is high output, resulting in derangement of fluid and electrolyte balance, a 
common reason for readmission. [19]  In our study, 12% of stoma patients were 
readmitted with fluid & electrolyte imbalance/failure to thrive, which was higher 
than the overall rate of 7% for all readmitted patients.   Paquette and colleagues 
performed a study evaluating the readmission rates for dehydration or acute 
kidney injury among pateints receiving new ileostomates from a single institution 
over the period 2007 to 2011. [19]  Out of the 201 patients eligible for 
readmission, 17% were readmitted within 30-days for dehydration or renal 
failure, which is slightly higher than was found in our study.   
While creation of temporary or permanent stomas remains a mainstay 
and important tool in the armamentarium of the surgeon, its creation is clearly 
associated with increased costs.  Strategies such as earlier clinic follow-up, 
more frequent home nurse visits, and perhaps even weekly phone-calls by 
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physician-extenders may need to be investigated further in an effort to reduce 
unnecessary and costly readmissions.  
Non-home discharge 
Several prior studies have identified non-home discharge status as a risk 
factor for readmission.[6, 10, 14]  We found up to 3 times increase risk for 
readmissions for non-home discharge, which has been corroborated by the 
findings from prior studies ([6, 10, 14]).  While our analysis adjusted for several 
factors related to the need for skilled nursing or inpatient rehabilitation, such as 
older age and occurrence of post-operative complications, we cannot determine 
whether the readmission risk was related to patient-factors that could not be 
adjusted for in our regression models, or if there is a risk inherent in non-home 
discharge itself.  Potential sources for increased readmission include additional 
exposure to healthcare associated infections, lower thresholds for sending 
patients back to the hospital, poor communication between the transferring 
institution and the accepting facility, or perhaps a diminished quality of care.[30], 
[31]  A study of Medicare beneficiaries requiring skilled nursing care following an 
acute care hospitalization suggested an inverse facility volume-outcome 
relationship with rehospitalization.[31]  An evaluation of the association between 
facility volume and readmission rates among non-Medicare surgical patients is 
required to further examine this relationship.  
Readmission prevention 
Not all readmissions are preventable.  Twenty percent of the readmitted 
patients in our study required a return to the operating room or percutaneous 
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abdominal drainage, and about one in five required ICU level care.  It’s unclear, 
however, given the nature of our database, whether some of the remaining 
readmissions could have been identified and treated prior to initial discharge.  
We are further limited by the lack of available data on the levels of care and 
resources in the outpatient setting, which, if appropriately utilized, could prevent 
unnecessary readmissions.  Patients requiring readmission for less urgent 
concerns may be treated appropriately in the outpatient setting.   
For example, a New York hospital performed a trial comparing 
readmission rates for adult patients following coronary artery bypass graft 
between those who had standard visiting nurse care, and those who had a 
cardiothoracic trained physician assistant (PA) make home visits on post-
operative days 2 and 5.[32]  Readmissions were reduced by 25% among 
patients receiving PA home visits.  The most significant drop in readmission 
rates occurred in wound-related complications, in which the readmission rates 
decreased from 44% to 19%.  This highlights a possible readmission reduction 
strategy in the CRS population, since 30% of readmissions in our study were 
due to surgical-site infections.  The costs of implementation of this strategy have 
to be balanced against the overall costs of readmission and its burden on the 
healthcare system. 
Another promising readmission prevention strategy that has recently 
received some press is by a startup company called Noora Health.  Their 
program works through an iPad app, which allows patients and their families to 
view a combination of videos, quizzes, and interactive content that teaches them 
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skills that will aid in their recovery once discharged. [33]  While hospitalized, 
patients and families are given 24-hour access to the app, and actually practice 
some of the skills they may need, such as changing a bandage, or assisting the 
family member out of bed to avoid falls.  The clinicians and nurses get reports on 
the progress so they may intervene and emphasize the skills they are struggling 
with.  This program is being tested in the United States, but has proven to be 
effective in India at a chain of low-cost hospitals run by Narayana Health.   
Future Areas of Research 
 At our institution, we plan to implement the use of a readmission risk 
prediction calculator.   We plan to prospectively collect the predicted 
readmission risk for patients who meet the inclusion criteria used in the present 
study and compare to observed readmission rates.  This will serve as a 
validation measure of the risk predictor.  When the risk predictor is validated, we 
can begin to implement interventions to assess for reduction in readmission risk.  
As we collect this data, it will alert us to high-risk patients.  For these patients, 
we plan to implement earlier clinic follow-up, and increased communication with 
any post-discharge care facilities the patients may go.  With these interventions 
we hope to reduce the readmission rates at our institution and expand to 
additional surgical patients and perhaps other institutions. 
Study Strengths/Limitations 
 In this study we were able to describe the outcomes of the readmission 
hospitalization.  Though prior reports have identified the readmission itself, there 
is a paucity of information on what actually occurs during the readmission.  
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Knowledge of this information allows for identification of potentially preventable 
readmissions. We also highlighted the additional costs attributed to readmission 
stays, which are critical for planning resource allocation for readmission 
reduction strategies.   
We acknowledge several important limitations of this paper.  Given the 
limitations of the database, we were unable to follow patients for longer than 30 
days.  However, the 30-day time point is used as a quality metric by CMS and is 
what penalizations are currently based on.  The database may have missed 
patients readmitted to non-UHC hospitals, or those that died in the non-hospital 
setting.  We believe this occurrence is low, given the similar readmission rates 
seen in other studies.[11, 12, 17] Patients evaluated in the emergency 
department and discharged home are not captured in the data.  Lastly, this 
database lacks true clinical data, including laboratory values, vital signs, 
inpatient/outpatient medications and other more specific clinical information 
which may aid in decision making with regards to early discharge and/or 
readmission.  Despite these limitations, we believe this study provides a scaffold 
on which to build and develop readmission prevention strategies. 
Conclusion 
 In summary, readmissions within 30-days of the index discharge occur in 
about 1 in 8 adults following colorectal surgery for benign or malignant 
conditions.  Predictive factors are clear and easily identified prior to hospital 
discharge, including LOS ≥4 days, ostomy, and non-home discharge. The 
significant risk of non-home discharge highlights a potential target for future 
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prevention strategies.  Certainly, the clinical and financial burden of 
readmissions warrant a closer look in an effort to improve care quality and 
reduce costs in a climate of excess healthcare spending. 
28
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Tables 
  
TABLE 1. Sociodemographic and baseline characteristics by 30-day readmission 
status for patients that survived index hospitalization for colorectal resection for 
cancer, diverticular disease, inflammatory bowel disease, or benign tumors from 
the UHC database between 2008-2011  (n = 70,484). 
 Readmitted 
(N =9,632) 
Not-Readmitted  
(N = 60,852) P-value 
Age, y, mean (SD) 58 (17) 59 (16) 0.003 
Male 4,940 (51) 30,523 (50) 0.05 
Race   <0.001 White 7,157 (74) 46,316 (76)  
Black 1,320 (14) 6,824 (11)  
Hispanic 69 (1) 391 (1)  
Asian 194 (2) 1,263 (2)  
Other 892 (9) 6,058 (10)  
Insurance Status   <0.001 Private 4,118 (43) 30,178 (50)  
Public 4,970 (52) 27,532 (45)  
Self-pay 74 (1) 509 (1)  
Other 470 (5) 3,633 (4)  
Comorbidities    Hypertension 4,648 (48) 27,196 (45) <0.001 
Diabetes 1,805 (19) 8,882 (15) <0.001 
Anemia 1,724 (18) 8,641 (14) <0.001 
    Chronic obstructive   
    pulmonary disease 1,379 (14) 7,186 (12) 
<0.001 
Obesity 1,150 (12) 6,225 (10) <0.001 
Congestive heart failure 560 (6) 2,022 (3) <0.001 
Depression 914 (9) 4,549 (7) <0.001 
Renal disease 622 (6) 2,352 (4) <0.001 
Peripheral vascular 
disease 350 (4) 1,639 (3) 
<0.001 
Liver disease 298 (3) 1,228 (2) <0.001 
SD = standard deviation 
“Other” Race = native american/eskimo, hawaiian/pacific-islander, multi-racial, 
other, unavailable, and declined; “Other” insurance status = military, auto, 
worker’s compensation, research, charity, and other.  
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TABLE 2. Procedure characteristics by 30-day readmission status for patients 
that survived index hospitalization for colorectal resection for cancer, 
diverticular disease, inflammatory bowel disease, or benign tumors from the 
UHC database between 2008-2011  (n = 70,484). 
 Readmitted 
(N =9,632) 
Not-
Readmitted  
(N = 60,852) 
P-value 
Admission Status   <0.001 
Elective 7,075 (73) 48,229 (80)  
Urgent 878 (9) 4,832 (8)  
Emergent 1,671 (17) 7,736 (13)  
Diagnosis   <0.001 
Colon cancer 3,261 (34) 22,663 (37)  
Rectal cancer 1,566 (16) 6,893 (11)  
Diverticular disease 2,048 (21) 15,797 (26)  
Ulcerative Colitis 1,052 (11) 3,943 (7)  
Crohn’s disease 958 (10) 5,095 (8)  
Benign tumor 747 (8) 6,461 (11)  
Procedure    <0.001 
Colectomy 7,073 (73) 48,605 (80)  
Right 2,454 (25) 18,180 (30)  
Transverse 184 (2) 1,241 (2)  
Left 728 (8) 4,652 (8)  
Sigmoid 2,104 (22) 17,620 (29)  
Total 1,251 (13) 4,774 (8)  
Other 672 (7) 3,327 (5)  
Low anterior resection 1,384 (14) 7,438 (12)  
Abdominoperineal resection 831 (9) 3,481 (6)  
Colon & rectal resection 344 (4) 1,328 (2)  
Stoma creation 3,793 (39) 14,714 (24) <0.001 
Surgical approach   <0.001 
Open 6,853 (71) 36,055 (59)  
Laparoscopic-assisted 2,660 (28) 24,021 (40)  
Robotic-assisted 119 (1) 776 (1)  
Surgeon volume category   <0.001 
Very High 14,608 (48) 30,008 (50)  
High 2,329 (24) 14,773 (24)  
Medium 1,556 (16) 9,655 (16)  
Low 1,139 (12) 6,416 (11)  
Hospital volume category   <0.001 
Very High 5,452 (57) 35,850 (59)  
High 2,419 (25) 14,535 (24)  
Medium 1,309 (14) 7,487 (12)  
Low 452 (5) 2,980 (5)  
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TABLE 3.   Index hospitalization outcomes by 30-day readmission status for patients 
that survived index hospitalization for colorectal resection for cancer, diverticular 
disease, inflammatory bowel disease, or benign tumor from the UHC database 
between 2008-2011  (n = 70,484). 
 Readmitted 
(N =9,632) 
Not-
Readmitted  
(N = 61,647) 
P-value 
Post-operative complication 1,249 (13) 4,788 (8) <0.001 
Wound related 842 (9) 3,326 (5) <0.001 
Other infectious (Urinary tract 
infection, pneumonia, sepsis) 
293 (3) 1,018 (2) <0.001 
Cardiovascular (Myocardial infarction, 
stroke, venous thromboembolism) 
148 (2) 453 (1) <0.001 
ICU admission 2,571 (27) 9,847 (16) <0.001 
ICU length of stay, d, median (SD) 3 (8) 2 (7) <0.001 
Reoperation 375 (4) 1,152 (2) <0.001 
Re-exploration 173 (2) 573 (1) <0.001 
Bowel resection 125 (1) 321 (1) <0.001 
Stoma creation/revision 213 (2) 573 (1) <0.001 
Anastomotic revision 39 (<1) 107 (<1) <0.001 
Percutaneous abdominal drain 
placement 
380 (4) 1,109 (2) <0.001 
Inpatient length of stay, days, median 
(SD) 
8 (10) 5 (7) <0.001 
Discharge status   <0.001 
Home 7,991 (83) 55,585 (91)  
Skilled nursing facility 1,065 (11) 3,752 (6)  
Rehabilitation facility 329 (3) 572 (<1)  
Other non-home facility 247 (3) 943 (2)  
ICU = intensive care unit  
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TABLE 4.   Univariate and multivariable analysis assessing risk factors for 30-day 
readmission (n = 9,632) for patients that survived index hospitalization for colorectal resection 
for cancer, diverticular disease, inflammatory bowel disease, or benign tumors from the UHC 
database between 2008-2011 (n = 70,484) 
 Unadjusted  
Odds Ratio 
(95% Confidence 
Interval) 
Adjusted  
Odds Ratio 
 (95% Confidence 
Interval) 
Age, per 10-year increase 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 
Female (vs. Male) 0.96 (0.92, 1.00) 0.99 (0.96, 1.04) 
Non-whitea (vs. White) 1.25 (1.17, 1.34) 1.09 (1.03, 1.14) 
Non-private insurance (vs. Private) 1.32 (1.27, 1.38) 1.28 (1.22, 1.35) 
High Severity of Illness (vs. Low) 1.71 (1.61, 1.83) 1.15 (1.07, 1.24) 
Urgent/Emergent Admission (vs. Elective) 1.38 (1.31, 1.45) 0.96 (0.90, 1.02) 
Diagnosis (vs. Benign tumor)   
      Diverticular disease 1.12 (1.03, 1.23) 0.89 (0.82, 0.98) 
      Inflammatory bowel disease 1.92 (1.76, 2.10) 1.32 (1.19, 1.46) 
      Cancer 1.41 (1.30, 1.53) 1.00 (0.92, 1.10) 
Colectomy (vs. Proctectomy) 1.44 (1.37, 1.51) 1.27 (1.21, 1.35) 
Stoma creation 2.03 (1.95, 2.13) 1.53 (1.45, 1.61) 
Open (vs. Laparoscopic/Robotic) 1.70 (1.63, 1.79) 1.24 (1.17, 1.31) 
Surgical complication 1.74 (1.63, 1.86) 1.13 (1.05, 1.22) 
Reoperation 2.10 (1.97, 2.37) 1.05 (0.91, 1.20) 
Percutaneous drain placement 2.12 (1.97, 2.49) 1.32 (1.16, 1.50) 
ICU admission 1.89 (1.79, 1.98) 1.36 (1.28, 1.44) 
Index length of stay ≥4 days (vs. <4 days) 2.19 (2.01, 2.38) 1.44 (1.32, 1.57) 
Discharge status (vs. Home)   
Skilled nursing facility 1.97 (1.83, 2.12) 1.63 (1.49, 1.76) 
Rehabilitation facility 4.00 (3.49, 4.59) 2.93 (2.54, 3.40) 
Other non-home facility 1.82 (1.58, 2.10) 1.23 (1.06, 1.43) 
Hospital volume category (vs. Low) 
      Medium 
 
1.15 (1.03, 1.29) 
 
1.20 (1.07, 1.35) 
      High 1.10 (0.99, 1.22) 1.17 (1.05, 1.31) 
      Very High 1.00 (0.90, 1.11) 1.11 (1.00, 1.24) 
aNon-white = Black, Asian, or Other  
bNon-private insurance = public, self-pay, other 
Multivariable model adjusted for all variables in the table. 
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TABLE 5.  Reasons for 30-day readmission for all readmitted patients, those with index 
length of stay ≥ 4 days, stoma creation, or non-home discharge (n = 9,632). 
 All 
patients 
(N = 9,632) 
Stoma 
creation 
 (N = 3,793) 
Length of 
stay ≥4 days 
(N = 8,995) 
Non-home 
discharge 
(N = 7,991) 
 No. (%) 
Gastrointestinal  2797 (29) 1029 (27) 2508 (28) 2511 (31) 
Surgical site related  2676 (28) 951 (25) 2515 (28) 2383 (30) 
          Organ space abscess 353 (13) 157 (17) 335 (13) 311 (13) 
          Deep wound infection 73 (3) 21 (2) 72 (3) 56 (2) 
          Superficial infection 2140 (80) 746 (78) 2007 (80) 1923 (81) 
          Hematoma/seroma 110 (4) 27 (3) 101 (4) 93 (4) 
Cardiovascular  173 (2) 48 (1) 164 (2) 108 (1) 
Bleeding  115 (1) 28 (1) 102 (1) 91 (1) 
Respiratory  183 (2) 61 (2) 175 (2) 127 (2) 
Genitourinary  454 (5) 279 (7) 447 (5) 354 (4) 
Deep vein 
thrombosis/pulmonary 
embolism  
192 (2) 60 (2) 183 (2) 148 (2) 
Neurological  69 (1) 24 (1) 68 (1) 40 (1) 
Fluid & electrolyte 
imbalance/failure to thrive  681 (7) 450 (12) 664 (7) 587 (7) 
Other infectious 414 (4) 172 (5) 396 (4) 284 (4) 
Other 1878 (20) 691 (18) 1773 (20) 1358 (17) 
Groups are not mutually exclusive, therefore the number of patients with length of stay ≥ 4 
days, stoma creation, and non-home discharge add up to >9,632 
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TABLE 6.  Reasons for 30-day readmission and outcomes of readmission encounter 
between early (≤7 days) and late (>7 days) readmission following colorectal resection for 
cancer, diverticular disease, inflammatory bowel disease, or benign tumors from the UHC 
database between 2008-2011 (n=9,632). 
 Early 
readmission 
(N = 4,923) 
Late 
readmission 
(N = 4,709) 
P 
Readmission diagnosis    <0.001 
Gastrointestinal  1,709 (35) 1,088 (23)  
Surgical site related  1,306 (27) 1,370 (29)  
Organ space 157 (12) 196 (14)  
Deep 34 (3) 39 (3)  
Superficial 1040 (80) 1100 (80)  
Non-infectious 75 (5) 35 (3)  
Cardiovascular  76 (2) 97 (2)  
Bleeding  83 (2) 32 (1)  
Respiratory  99 (2) 84 (2)  
Genitourinary  139 (3) 315 (7)  
Venous thromboembolism  88 (2) 104 (2)  
Neurological  33 (1) 36 (1)  
Fluid & Electrolyte/Malnutrition  322 (7) 359 (8)  
Other infectious 172 (3) 172 (5)  
Other 896 (18) 982 (21)  
Reoperation during readmission 
encounter 395 (8) 
181 (4) <0.001 
Abdominal exploration 100 (25) 47 (26)  
Stoma creation/revision 274 (69) 105 (58)  
Bowel resection 21 (5) 29 (16)  
Percutaneous abdominal drain 800 (17) 668 (14) <0.001 
ICU admission during readmission 
encounter 705 (14) 
543 (12) <0.001 
Readmission length of stay, d, median 
(SD) 5 (8) 
4 (7) <0.001 
Non-home readmission discharge 649 (14) 584 (13) NS 
Death during readmission stay 91 (2) 72 (2) NS 
Readmission total direct cost, $, 
median (SD) $4,489 ($22,120) 
$4,396 ($8,196) <0.001 
Combined total direct cost*  $19,739 
($29,264) 
$19,654 
($28,902) 
<0.001 
ICU = intensive care unit, SSI= surgical site infection, DVT = deep vein thrombosis, PE = 
pulmonary embolism 
*index encounter + readmission encounter 
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Figure 1.  Distribution of time to readmission (median = 7 days) 
